Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scintacor is a global leader in the development and manufacture of phosphor and scintillation products for radiation detection and imaging applications. The company specializes in converting various forms of radiation, including X-rays, neutrons, and electrons, into visible light to enable high-resolution digital imaging. Their technology is critical for medical and dental diagnostics, life science research, and industrial non-destructive testing. Scintacor provides both standard and custom-designed scintillation screens, coatings, and fiber optic components to global OEM partners. Based in Cambridge, UK, the company operates as a subsidiary of the SDI Group, leveraging over a century of expertise in materials science and vacuum deposition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scintacor.